Molecular Intervention with Plasma-Rich Growth Factors to Enhance Muscle Perfusion and Tissue Remodeling in Ischemic Diseases
Ischemic diseases remain the first cause of morbidity and mortality worldwide. Current standard approaches based on drug-therapy or surgery have a palliative but not a repairing effect, which leads to chronification and worsening of the disease.
Unable to display preview. Download preview PDF.